| ||
| Every Second Counts, Every Action Matters: The Heart Rescue Project EmpowHer To put this in perspective, that's more than deaths from AIDS, breast cancer and lung cancer combined. Because SCA provides no advanced warning, it's critical that victims receive immediate medical intervention such as defibrillation. The survival rate ... See all stories on this topic » | ||
| New drug approved for battle against melanoma. NorthJersey.com Researchers will now start looking to use the drug to fight other types of cancer, including lymphoma, renal cell and possibly some forms of lung cancers, Pecora said. "Melanoma is very sensitive to an immune system, response so we'll try using it for ... See all stories on this topic » | ||
| Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer PR Newswire (press release) Abnormal Hh signaling has been implicated in several types of cancer, including brain, lung, breast, prostate and skin cancers. Abnormal Hh pathway activation can result from genetic mutations in the pathway's protein components. ... See all stories on this topic » | ||
| Jennerex and Transgene Announce the Presentation of Positive Clinical Data of ... PR Newswire (press release) "We look forward to reporting additional clinical results in patients with advanced liver cancer from two ongoing studies—a randomized Phase 2 trial of JX-594 evaluating survival across two dose groups, and a Phase 2 clinical trial evaluating JX-594 ... See all stories on this topic » | ||
| Soy Aids Radiation's Ability to Kill Cancer Cells Laboratory Equipment "To improve radiotherapy for lung cancer cells, we are studying the potential of natural non-toxic components of soybeans, called soy isoflavones, to augment the effect of radiation against the tumor cells and at the same time protect normal lung ... See all stories on this topic » | ||
| Cerulean Pharma Inc. Presents Phase 2a Clinical Data at American Association ... Genetic Engineering News (press release) Furthermore, the poster also includes preliminary clinical activity data that highlight observations of stable disease in advanced non-small cell lung carcinoma (NSCLC) patients. Specifically, the interim data show that 70% of the NSCLC patients ... See all stories on this topic » | ||
| Source: Tekmira Pharmaceuticals GlobeNewsWire (press release) TKM-PLK1 has been shown in preclinical animal studies to selectively kill cancer cells, while sparing normal cells in healthy tissue. PLK1 plays a key role in a number of significant cancer indications including colorectal, breast, non-small cell lung, ... See all stories on this topic » | ||
| Dendreon: A Pipeline That's the Envy of Big Pharma Seeking Alpha PROTECT is continuing to track data for TTDM as well as Overall Survival (OS). Both endpoints are event-driven. Although the company has not published when they expect sufficient events will be collected for TTDM or OS, I believe that for TTDM, ... See all stories on this topic » | ||
| Oncothyreon Presents Preclinical Data for ONT-10 and PX-866 at American ... PR Newswire (press release) ONT-10 is a therapeutic vaccine targeting MUC1, a tumor-associated antigen present on many types of human malignant tumors, including lung, breast, colorectal, prostate and ovarian cancer. ONT-10 contains a forty three amino acid antigen which is ... See all stories on this topic » | ||
| 3 Biotechs With Momentum Ahead of ASCO Seeking Alpha The company has 2 other trials running testing Bavituximab in non-small cell lung cancer (NSCLC), both of which should have data readouts in the second half of 2011. For now, we want to keep the expectations for success in this indication low, ... See all stories on this topic » |
| ||
| Amgen, Takeda drug fails advanced lung-cancer study (Reuters) Takeda and Amgen's drug for lung cancer fails in a late-stage trial: [ + ]. Investigational drug motesanib did not improve overall survival of patients with ... www.bioportfolio.com/.../Amgen-Takeda-Drug-Fails-Advance... | ||
| stage iv esophageal cancer survival rate | Healthy Tips When High Blood Pressure Is Dangerous For Cholesterol Level · Afatinib (BIBW 2992*) Triples Progression Free Survival in Phase III Study in Lung Cancer ... healthytips.dflix.net/.../stage-iv-esophageal-cancer-survival-rat... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment